Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Frontier Biotechnologies enters agreement with Rockefeller University

July 26, 2017

ALT-803 induces NK- and T-cell activation in SIV-infected macaques

July 26, 2017

EMA committee backs approval of Janssen's Symtuza

July 24, 2017

Merck & Co. divulges HIV integrase inhibitors

July 17, 2017

Gilead Sciences' MAA for bictegravir/emtricitabine/tenofovir alafenamide FDC validated by EMA

July 14, 2017

FDA gives ibalizumab BLA priority review

July 3, 2017

ViiV Healthcare presents novel anti-HIV compounds

June 20, 2017

Gilead Sciences submits NDA in U.S. for bictegravir/emtricitabine/tenofovir alafenamide

June 13, 2017

NIH funds collaborative New York Center for AIDS Research

June 12, 2017

Merck & Co. discloses novel HIV integrase inhibitors

June 8, 2017

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...